report- Acute-Myelocytic-Leukemia-AML-Acute-Myeloblastic-L | Page 3

Table of Contents Table of Contents 2 List of Tables 5 List of Figures 5 Report Guidance 7 Clinical Trials by Region 8 Clinical Trials and Average Enrollment by Country 9 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12 Top Five Countries Contributing to Clinical Trials in Europe 13 Top Countries Contributing to Clinical Trials in North America 14 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15 Top Five Countries Contributing to Clinical Trials in Central and South America 16 Clinical Trials by G7 Countries: Proportion of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) to Oncology Clinical Trials 17 Clinical Trials by Phase in G7 Countries 19 Clinical Trials in G7 Countries by Trial Status 20 Clinical Trials by E7 Countries: Proportion of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) to Oncology Clinical Trials 21 Clinical Trials by Phase in E7 Countries 23 Clinical Trials in E7 Countries by Trial Status 24 Clinical Trials by Phase 26 In Progress Trials by Phase 27 Clinical Trials by Trial Status 28 Clinical Trials by End Point Status 30 Subjects Recruited Over a Period of Time 31 Clinical Trials by Sponsor Type 32